Episode 375: Renal Cancer 2024 Highlights

By The Uromigos - Last Updated: December 26, 2024

Dr. David McDermott joins the podcast to review the top data from 2024 in the renal cell carcinoma field, including the recent KEYNOTE-564 results.

Post Tags:Uromigos-Kidney Cancer
Advertisement

Related Podcasts

Episode 384: ASCO GU Preview
Episode 383: A Neoantigen Vaccine Generates Anti-Tumor Immunity in RCC
Uromigos-Kidney Cancer
Episode 381: Molecular Heterogeneity in Urothelial Carcinoma and Determinants of Clinical Benefit to PD-L1 Blockade
Uromigos-Bladder Cancer
Episode 380: The Role of SBRT in RCC
Uromigos-Kidney Cancer
Episode 378: 2025 Preview of Important GU Data
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |